Healio

Alpha-defensin lateral-flow test yields high sensitivity, specificity for periprosthetic joint infection

Please provide your email address to receive an email when new articles are posted on . In a prospective, multicenter, adjudicator blinded clinical trial, Carl A. Deirmengian, MD, FAAOS, and ...
The American Journal of Managed Care

Liquid Biopsy to Detect Early-Stage Liver Cancer Shows Higher Sensitivity, Specificity

Researchers said the blood test offers an earlier warning of hepatocellular carcinoma than current methods. Recent research highlights the increased sensitivity and specificity of a blood test to ...
ascopubs.org

Sensitivity and specificity of osteopontin (OPN) versus prostate-specific antigen (PSA) in prostate carcinoma (PCa): A case- control study

Cisplatin (C) and gemcitabine (G) chemotherapy with concurrent irradiation (XRT), for the conservative treatment of invasive transitional bladder cancer (ITBC) patients: Clinical outcome and long-term ...
BMJ

2.21 The test-retest reliability, sensitivity and specificity of the SCAT-3 for sideline testing

Conclusions Symptoms, the SAC and the m-BESS have poor test-retest reliability. Symptoms have reasonable sensitivity and specificity for concussion but are subjective. The 3-word SAC and m-BESS are ...
Healio

Revised criteria may ‘substantially reduce racial disparities’ in lung cancer screening

Please provide your email address to receive an email when new articles are posted on . An alternative LCS criteria had higher sensitivity and specificity vs. the USPSTF’s current criteria. The ...
Targeted Oncology

Blood-Based Colorectal Cancer Test Shows High Sensitivity in APLs

A blood-based colorectal cancer (CRC) screening test, SimpleScreen™, has shown a significant leap in performance, ...
Morningstar

Natera Reports Strong Advanced Adenoma Data from Prospective PROCEED-CRC Trial, Demonstrating 22.5% Sensitivity and 91.5% Specificity

Natera Reports Strong Advanced Adenoma Data from Prospective PROCEED-CRC Trial, Demonstrating 22.5% Sensitivity and 91.5% Specificity Findings underscore strength of Natera’s technology for early ...
Nasdaq

Next-generation Cologuard Test Demonstrates 94 Percent Sensitivity for Colorectal Cancer at 91 Percent Specificity, Raising the Bar in Non-invasive Screening

Note: specificity including non-advanced findings includes colonoscopy results that were negative for cancer or advanced precancer upon histopathological review; specificity including no findings ...